GABRIEL LEUNG
CIK 1236183 · EVP & Pres. Pharma. Business · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.05M
Companies
5
Total Filings
79
Lifetime Open-Market Net
-$28.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 101,109 | $17.78 | $1.80M | -$24.16M | 44 | 2026-06-05 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 3 | 2018-05-23 |
| ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Director | 31,316 | — | — | $19.2K | 9 | 2015-03-04 |
| DCTH | Director | 21,485 | $11.72 | $251.8K | $11.8K | 7 | 2014-07-09 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | EVP & Pres. Pharma. Business | 0 | — | — | -$4.15M | 16 | 2010-06-09 |
Recent Filings · Page 6 of 8
79 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-11-01 | DCTH | Grant (A) | +16,500 | $0 | EDGAR |
| 2013-06-07 | DCTH | Grant (A) | +33,000 | $0 | EDGAR |
| 2013-02-04 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | +5,843 | $35.0K | EDGAR |
| 2012-06-19 | DCTH | Grant (A) | +32,680 | $0 | EDGAR |
| 2012-06-18 | DCTH | Buy (P) | +7,500 | $11.8K | EDGAR |
| 2012-06-14 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-07 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | +6,224 | $15.0K | EDGAR |
| 2011-12-07 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Buy (P) | +8,000 | $19.2K | EDGAR |
| 2011-06-09 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-06-03 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | +2,918 | $15.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.